Cytokinetics

CYTK

Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Cytokinetics has been a target of short sellers for a while. The current short interest of 14.02% is roughly at the average of the last 12 months (12.10%).